Curaleaf Holdings, Inc. (CURA.CN)
| Previous Close | 4.7600 |
| Open | 4.6800 |
| Bid | 4.9200 x 0 |
| Ask | 5.0300 x 0 |
| Day's Range | 4.6000 - 5.0800 |
| 52 Week Range | 4.4200 - 11.5300 |
| Volume | |
| Avg. Volume | 426,805 |
| Market Cap | 3.587B |
| Beta (5Y Monthly) | 1.92 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Baystreet
Stocks in play: Curaleaf Holdings Inc
Announces it has been approved by the Connecticut Department of Consumer Protection to commence adult-use ...
- Yahoo Finance Video
Marijuana legalization is ‘at least three-plus years away’: TerrAscend exec
Curaleaf CEO Matt Darin and TerrAscend Executive Chairman Jason Wild sit down with Yahoo Finance to break down the cannabis industry's outlook for federal legalization in the U.S. and the growth seen despite Congress' stalling of the SAFE Banking Act.
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Columbia Care released its first report on corporate social responsibility. Curaleaf expanded “The Farmer’s Select” collaboration with Autumn Brands. Key Takeaways; Psychedelic Sector Awakn saw significant gains after recording impressive revenue growth in Q3 2022; The company also announced a Phase III clinical trial for its ketamine-assisted therapy. Revive announced expansion […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first
